Protein Arrays Hindered By Lack of Content, Patent Issues, Antibody Costs and Logistics | GenomeWeb

BOSTON — Though the protein arrays market is growing by about 28 percent per year, it is hindered by a lack of content, difficulties in setting up business partnerships with antibody companies, and legal problems involving patents, analysts specializing in protein arrays said here this week at IBC’s protein arrays conference.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.